Manufacture of pharmaceutical preparations
HP HALDEN PHARMA AS
Revenue 2024
NOK 1.3bn
Operating profit
NOK 76.3m
Equity
NOK 57.8m
Incorporated
2023
Employees
694
Share capital
NOK 7.8m
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 1.3bn | |
| Total operating costs | 1.2bn | |
| Operating profit (EBIT) | 76.3m | |
| Net financial items | −14.9m | |
| Profit for the year | 47.8m |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 815.2m | |
| of which current assets | 757.6m | |
| Equity | 57.8m | |
| Total liabilities | 757.4m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.